EG14400A - Phenethanolamines formulations and potentiation of oncolytic drugs - Google Patents

Phenethanolamines formulations and potentiation of oncolytic drugs

Info

Publication number
EG14400A
EG14400A EG386/79A EG38679A EG14400A EG 14400 A EG14400 A EG 14400A EG 386/79 A EG386/79 A EG 386/79A EG 38679 A EG38679 A EG 38679A EG 14400 A EG14400 A EG 14400A
Authority
EG
Egypt
Prior art keywords
phenethanolamines
potentiation
formulations
oncolytic drugs
oncolytic
Prior art date
Application number
EG386/79A
Other languages
English (en)
Inventor
Jack Mills
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of EG14400A publication Critical patent/EG14400A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EG386/79A 1978-07-03 1979-06-27 Phenethanolamines formulations and potentiation of oncolytic drugs EG14400A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92166878A 1978-07-03 1978-07-03

Publications (1)

Publication Number Publication Date
EG14400A true EG14400A (en) 1983-12-31

Family

ID=25445786

Family Applications (1)

Application Number Title Priority Date Filing Date
EG386/79A EG14400A (en) 1978-07-03 1979-06-27 Phenethanolamines formulations and potentiation of oncolytic drugs

Country Status (33)

Country Link
EP (2) EP0047536B1 (fr)
JP (1) JPS559100A (fr)
AR (2) AR222658A1 (fr)
AT (1) AT370408B (fr)
AU (1) AU521744B2 (fr)
BE (1) BE877392A (fr)
BG (3) BG40480A3 (fr)
CA (1) CA1120058A (fr)
CH (1) CH641759A5 (fr)
CS (2) CS208660B2 (fr)
DD (1) DD144763A5 (fr)
DK (1) DK268579A (fr)
EG (1) EG14400A (fr)
ES (2) ES482153A1 (fr)
FI (1) FI67686C (fr)
FR (1) FR2430409A1 (fr)
GB (1) GB2028800B (fr)
GR (1) GR72546B (fr)
HK (1) HK44087A (fr)
HU (1) HU179170B (fr)
IE (1) IE48436B1 (fr)
IL (1) IL57670A (fr)
LU (1) LU81456A1 (fr)
MX (1) MX6160E (fr)
MY (1) MY8500596A (fr)
NZ (1) NZ190859A (fr)
PH (1) PH15650A (fr)
PL (2) PL123990B1 (fr)
PT (1) PT69840A (fr)
RO (2) RO77731A (fr)
SU (2) SU965351A3 (fr)
YU (1) YU154879A (fr)
ZA (1) ZA793295B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006735B1 (fr) * 1978-06-28 1983-06-15 Beecham Group Plc Amines secondaires, procédé pour leur préparation, compositions pharmaceutiques les contenant et leur utilisation
NL8105170A (nl) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
EP0068669A1 (fr) * 1981-06-20 1983-01-05 Beecham Group Plc Phényléthanolamines secondaires, procédés de leur préparation et leur application pharmaceutique
CA1219865A (fr) * 1982-05-14 1987-03-31 Leo Alig Derives de phenethanolamine d'aziridine
CA1258454A (fr) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
EP0102213A1 (fr) * 1982-08-21 1984-03-07 Beecham Group Plc Dérivés de l'éthanolamine, compositions pharmaceutiques les contenant et procédés pour leur préparation
SU1523043A3 (ru) * 1983-01-31 1989-11-15 Эли Лилли Энд Компани (Фирма) Способ кормлени сельскохоз йственных животных и птицы
US4849453A (en) * 1983-01-31 1989-07-18 Eli Lilly And Company Growth promotion
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines
JPS62155213A (ja) * 1985-12-20 1987-07-10 イ−ライ・リリ−・アンド・カンパニ− 腫瘍細胞崩壊剤
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
US5051423A (en) * 1988-07-13 1991-09-24 Schering Ag Derivatized alkanolamines as cardiovascular agents
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
CN1073983C (zh) * 1994-10-31 2001-10-31 中国科学院成都有机化学研究所 一种β－拟肾上腺素兴奋剂型饲料添加剂的合成方法
JP4448902B2 (ja) 2001-06-08 2010-04-14 株式会社医薬分子設計研究所 スルホンアミド誘導体
TW200740779A (en) 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6610530A (fr) * 1966-07-27 1968-01-29
BE757005A (fr) * 1969-10-02 1971-04-02 Bristol Myers Co Phenethanolamines substituees et procede pour leur preparation
US3801631A (en) * 1972-02-16 1974-04-02 Mead Johnson & Co 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts

Also Published As

Publication number Publication date
AR222658A1 (es) 1981-06-15
PL119783B1 (en) 1982-01-30
FI67686B (fi) 1985-01-31
PL123990B1 (en) 1982-12-31
SU965351A3 (ru) 1982-10-07
PL222867A1 (fr) 1981-01-02
AR222727A1 (es) 1981-06-15
JPS559100A (en) 1980-01-22
ZA793295B (en) 1981-02-25
FI67686C (fi) 1985-05-10
IL57670A (en) 1982-11-30
IE48436B1 (en) 1985-01-23
IL57670A0 (en) 1979-10-31
IE791231L (en) 1980-01-03
EP0047536A2 (fr) 1982-03-17
CH641759A5 (fr) 1984-03-15
RO83053B (ro) 1984-02-28
BE877392A (fr) 1980-01-02
GR72546B (fr) 1983-11-17
FR2430409B1 (fr) 1981-05-29
ES8101537A1 (es) 1980-12-16
EP0047536A3 (en) 1982-03-24
PT69840A (en) 1979-07-01
AT370408B (de) 1983-03-25
HU179170B (en) 1982-08-28
RO77731A (fr) 1981-11-24
BG40481A3 (en) 1986-12-15
AU4848879A (en) 1980-01-10
JPS636058B2 (fr) 1988-02-08
DD144763A5 (de) 1980-11-05
EP0007206B1 (fr) 1983-02-23
FR2430409A1 (fr) 1980-02-01
GB2028800A (en) 1980-03-12
HK44087A (en) 1987-06-12
SU931102A3 (ru) 1982-05-23
NZ190859A (en) 1984-09-28
EP0007206A1 (fr) 1980-01-23
RO83053A (fr) 1984-02-21
DK268579A (da) 1980-01-04
BG40482A3 (en) 1986-12-15
LU81456A1 (fr) 1979-10-30
CA1120058A (fr) 1982-03-16
BG40480A3 (en) 1986-12-15
CS208660B2 (en) 1981-09-15
MX6160E (es) 1984-11-29
CS208661B2 (en) 1981-09-15
EP0047536B1 (fr) 1984-06-27
PL216810A1 (fr) 1980-07-28
ES487847A0 (es) 1980-12-16
GB2028800B (en) 1982-11-03
AU521744B2 (en) 1982-04-29
ES482153A1 (es) 1980-08-16
PH15650A (en) 1983-03-11
MY8500596A (en) 1985-12-31
FI792080A (fi) 1980-01-04
ATA463979A (de) 1982-08-15
YU154879A (en) 1983-04-30

Similar Documents

Publication Publication Date Title
EG14400A (en) Phenethanolamines formulations and potentiation of oncolytic drugs
JPS54119025A (en) Tickening of cosmetic * pharmaceutical and technical preparation
DE2964091D1 (en) Phenethanolamines, their formulations, use and preparation
IL64573A (en) Derivatives of formylphenoxyalkanoic acids and formylphenoxymethylbenzoic acids,their preparation and pharmaceutical formulations containing them
ZA79796B (en) Oral products and their preparation
NZ189378A (en) 4-amino-5-alkylsulphonyl-ortho-anisamdes and pharmaceutical compositions
NZ190784A (en) Benzofuranyl-piperidines and pharmaceutical compositions
DE2963797D1 (en) Amino-dibenzopyrans, their preparation, formulations containing them and their use as pharmaceuticals
DE2963061D1 (en) Hydantoin compounds, their preparation and pharmaceutical formulations containing them
PH20604A (en) Improvements in or relating to indanyl derivatives and pharmaceutical preparations containing them
IL57040A0 (en) Mercaptoimidazole derivatives their preparation and pharmaceutical compositions containing them
NZ191102A (en) Pharmaceutical formulations of galactomannan
IL56678A0 (en) Substituted2-phenyl imino-inidazolidines and salts thereoftheir preparation and pharmaceutical compositions containing them
IL57599A0 (en) Indolealkylamines,pharmaceutical formulations containing these and processes for their preparation
MY8500281A (en) Pharmaceutical and food formulations
ZA79395B (en) Pharmaceutical formulations
NZ191981A (en) Pharmaceutical composition containing amoxycillin and polyvinylpyrrolidone
NZ190521A (en) Phenylamino-thiophenacetic acids and pharmaceutical compositions
DE2960506D1 (en) Arylimidazoles, their synthesis and pharmaceutical or veterinary preparations containing them
ZA793131B (en) Indolealkylamines,pharmaceutical formulations containing these,and processes for their preparation
ZA793923B (en) Medicinal formulation
NZ189896A (en) Phenylaniline derivatives and pharmaceutical compositions
IL58620A0 (en) Aryltrifluoroethanol derivatives their preparation and pharmaceutical compositions containing them
GB2029411B (en) 1-benzoyl-3-pyridinyl ureas their use preparation and formulations
NZ189279A (en) Arylaminoimidazolines and pharmaceutical compositions